Abstract
Role of Positron Emission Tomography (PET) with F-18-2-fluoro-2-deoxy-D- glucose (FDG) in staging of Hodgkin disease is well established despite several controversies. We report a Stage III Hodgkin lymphoma patient with false positive FDG-PET/CT results. Seven-year-old male with Hodgkin lymphoma was in remission at end of chemotherapy. At third and fourth months of postchemotherapy follow-up, increased gallium uptake and positive FDG-PET/CT in right lower quadrant of abdomen was observed. Open biopsy revealed lymphoid hyperplasia. He has been followed for 21 months without any evidence of disease. Despite its documented benefit, we believe that results of FDG-PET/CT should be interpreted with great caution in order to avoid unnecessary interventions.
Original language | English (US) |
---|---|
Pages (from-to) | 881-883 |
Number of pages | 3 |
Journal | Pediatric Blood and Cancer |
Volume | 50 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2008 |
Keywords
- FDG-PET/CT
- False positivity
- Hodgkin
- Lymphoma
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology